Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,660 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05294055RecruitingPhase 2
Mecapegfilgrastim to help collect stem cells for transplant
This Phase 2 study tests mecapegfilgrastim with chemotherapy to help your body collect enough peripheral blood stem cells for an autologous transplant (using your own cells). It’s for people with multiple myeloma or certain lymphomas who have already had some response to treatment.
Hefei, AnhuiAges 18–65 - NCT05294276Recruiting
Newborn registry for very small or very early babies
This study registers newborns who are very small or born very early, to better understand their care and outcomes over time. If you have a newborn that fits the size or gestational age range and the baby is delivered at or transferred to the hospital, you may be eligible.
TaipeiAges Up to 1 year - NCT05294107Recruiting
Intestinal organoid study in digestive biopsies
This study collects small tissue samples (biopsies) during a routine endoscopy to create organoids—miniature versions of your intestine grown in a lab. The goal is to better understand digestive diseases and test potential treatments. You may be eligible if you're already scheduled for an endoscopy.
RennesAges 18–75 - NCT05295212RecruitingPhase 2
Atezolizumab plus chemo before surgery for lung cancer
This trial studies whether adding atezolizumab (an immune medicine) to standard platinum-based chemotherapy before surgery can improve outcomes for operable stage II–IIIB non-small cell lung cancer. The goal is to shrink the tumor and increase the chance the cancer can be removed with better results.
Changsha, HunanAges 18 years+ - NCT05296954Recruiting
Mapping the heart’s pathways in certain fast rhythms
This study uses a high-resolution heart mapping system to locate where certain fast, re-entrant heart rhythms start and travel. It may help doctors better target treatments, especially when the rhythm comes from within the heart’s electrical “node” area.
ToulouseAges 18 years+ - NCT05297708Recruiting
Blood pressure monitoring at home, office, and with a 24-hour device
This study compares blood pressure readings taken at home, in the doctor's office, and over a full 24-hour period using a portable monitor. It may help understand the best way to track blood pressure in children and teens with slightly high blood pressure.
Cincinnati, OhioAges 6–19 - NCT05298995RecruitingPhase 1
GD2 CAR T-cell treatment for pediatric brain tumors
This trial tests a special immune-cell therapy (GD2 CAR T cells) made for pediatric brain tumor patients. It uses a planned treatment plan and monitoring to see if the therapy is safe and can work against the tumor.
Roma, ItalyAges 6 months–30 years - NCT05298722Recruiting
MRI and blood tests to predict if pancreatic surgery is possible
This study looks at MRI scans, computer-extracted imaging features, and blood/“liquid biopsy” tests after FOLFIRINOX chemotherapy to predict whether surgery can fully remove pancreatic cancer. It may help your care team choose the best next step—whether surgery is likely to be possible and how to plan it.
Ghent, East FlandersAges 18 years+ - NCT05303285RecruitingPhase 4
Secukinumab for active ankylosing spondylitis in Chinese adults
This trial studies whether secukinumab (a targeted medicine given by injection) can reduce symptoms and disease activity in adults with active ankylosing spondylitis. You may be considered if other common anti-inflammatory medicines have not worked well enough or you could not take them.
Wuhan, HubeiAges 18–80 - NCT05302531RecruitingPhase 1
Testing high-absorption antibiotics for short-bowel syndrome
This early (Phase 1) study tests how well certain antibiotics get absorbed in the body when you have short-bowel syndrome. It may help doctors choose antibiotics that work better through the mouth for people with this digestion problem.
Vandœuvre-lès-Nancy, LorraineAges 18 years+ - NCT05303896Recruiting
Study changes in remodeling heart tissue before transplant
This study looks at how the heart’s structure changes (“remodeling”) in people with heart failure who are being considered for a heart transplant. It may help doctors better understand what is happening in the failing heart and how to treat it.
Oslo, OsloAges 18–100 - NCT05304286Recruiting
Study of brain and pain in long-lasting post-surgery pain
This trial studies what’s happening in the brain and how pain is processed in people with pain that lasts long after surgery. It may help researchers understand chronic post-surgical pain and find better ways to treat it.
Boston, MassachusettsAges 12 years+ - NCT05305092Recruiting
Study of memory and thinking in early breast cancer
This study checks how breast cancer affects memory and thinking before other treatments start. It may help doctors better understand cognitive changes and who is most at risk.
Xi'an, ShaanxiAges Any age - NCT05305131RecruitingPhase 2
Testing chemotherapy with or without extra cancer medicines for nasopharyngeal cancer
This Phase 2 study compares standard chemotherapy (gemcitabine plus cisplatin) against the same chemotherapy plus pembrolizumab and bevacizumab. It aims to see which combination works better for EBV-positive nasopharyngeal cancer before any prior treatment.
SingaporeAges 1.8 years–99 years - NCT05305313RecruitingPhase 4
Testing a new propofol dosing method for higher BMI surgeries
This trial studies whether adjusting how propofol (an anesthesia medicine) is dosed based on total body weight improves anesthesia delivery during longer surgeries. It mainly targets people with a higher body mass index having surgery that lasts over an hour.
New Delhi, National Capital Territory of DelhiAges 18–65 - NCT05305859RecruitingPhase 2
Venetoclax, chidamide, and azacitidine for hard-to-treat AML
This Phase 2 trial tests whether adding three medicines—venetoclax, chidamide, and azacitidine—can help adults whose AML has come back or did not respond to treatment. It may help shrink or control the leukemia and improve outcomes for people who fit the study’s health and lab requirements.
Xiamen, FujianAges 18 years+ - NCT05306509Recruiting
Early palliative care talks for kids with cancer
This trial tests whether nurse-led conversations about comfort and support (palliative care) early in a child’s cancer journey can help families and the child cope better. It is focused on newly diagnosed or relapsed pediatric cancer patients in Chinese-speaking settings.
Shanghai, MinhangAges Up to 18 years - NCT05306834Recruiting
Study to slow memory decline by targeting hidden small brain vessel disease
This trial looks at how to slow cognitive decline and early dementia in people with a specific kind of “silent” blood vessel damage in the brain seen on scans. It may help identify whether targeting this hidden condition can protect thinking and memory over time.
BordeauxAges 60–88 - NCT05308628Recruiting
Tests for liver scar (fibrosis) in children after liver transplant
This study checks how well a liver “fibrosis panel” test can evaluate scarring in children who have had their first liver transplant. Your child may be helped by getting extra monitoring of liver scarring, and the study may improve how doctors assess recovery and risk over time.
ShanghaiAges 2 months–18 years - NCT05306912Recruiting
Test gene analysis on liquid from a lung biopsy
This study looks at special lab tests (molecular analysis) done on liquid taken during a bronchoscopy to better understand lung nodules. It may help doctors learn more about what these nodules are, using samples from the procedure.
Toulouse, OccitanieAges 18 years+ - NCT05307731RecruitingPhase 4
Fingolimod for adults with type 2 diabetes
This trial studies whether fingolimod can improve diabetes in adults with type 2 diabetes who are not yet on many medications. It will mainly check whether the drug is safe and whether it can help control blood sugar over time.
ShenyangAges 18–70 - NCT05308888RecruitingPhase 2
PET scan study of heart inflammation after aortic valve replacement
This Phase 2 trial uses a PET scan to study how local inflammation inside the heart affects the heart’s electrical wiring after a minimally invasive aortic valve procedure. The results may help doctors better predict or prevent rhythm and conduction problems after treatment.
BrestAges 18 years+ - NCT05309863Recruiting
Compare home versus clinic weight programs for fatty liver
This study compares two weight-loss programs for children with fatty liver disease related to weight, to see which helps the liver and health better. You may be eligible if your child is already enrolled in a lifestyle program for childhood obesity and meets key safety checks.
Ghent, East-FlandersAges 8–18 - NCT05311137Recruiting
Closed-loop monitoring for atrial fibrillation
This study tests a “closed-loop” approach to treating atrial fibrillation, meaning the care plan may adjust based on how you’re doing. It may help improve how heart rhythm problems are managed over time.
Shanghai, Shanghai MunicipalityAges 18–100
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,660 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.